We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gene Therapy Trial Resumes After Patient Death
Gene Therapy Trial Resumes After Patient Death
November 28, 2007
The FDA has removed the hold on Targeted Genetics’ Phase I/II clinical trial of a gene therapy treatment for inflammatory arthritis after an investigation concluded that the drug did not contribute to the July 24 death of a patient.